Patients with Lupus Nephritis-Related Kidney Disease Are Living Longer
March 28, 2019
A new study published this March in Arthritis & Rheumatology found that deaths among patients with end-stage...
News
NOT TOO LATE: Join Our 15th Annual Advocate for Lupus Research Day – THROUGH NEXT WEEK!
Lupus purple was seen throughout the Capitol this week when advocates representing the Lupus Research Alliance visited Congress to...
Lupus Research Alliance Advocates Call on Congress to Fund More Lupus Scientific Exploration
WASHINGTON, DC – March 19. Lupus Research Alliance (LRA), the world’s largest private funder of lupus research, celebrates its...
Study Finds Mycophenolate Mofetil Comparable to Standard Treatment for Pediatric Lupus Nephritis
March 19, 2019
A new study published in Lupus showed that mycophenolate mofetil (MMF) is comparable in effectiveness to the...
Thank you 2019 Half-Marathon Team Life Without Lupus!
Thanks to the Lupus Research Alliance Team Life Without Lupus, with runners who pounded the pavements at the United...
LRA-Supported Researchers Developed a Model to Predict Full-Blown Lupus Nephritis Down the Road
A new study funded by the Lupus Nephritis Trials Network with support from the Lupus Research Alliance has proposed...
Peripheral Nervous System Involvement in Systemic Lupus Erythematosus: A Retrospective Study on Prevalence, Associated Factors and Outcome
A new study published in the peer-reviewed journal Lupus shows that lupus can cause damage to the peripheral nervous...
Lupus Research Alliance and National Minority Quality Forum Release Recommendations to Advance New Lupus Treatments by Increasing Diversity in Clinical Trial Participation
NEW YORK, NY. March 14, 2019. The Lupus Research Alliance (LRA) and the National Minority Quality Forum (NMQF) today...
Frailty Measure Predicts Mortality Risk Among People with Lupus
March 11, 2019
A new study published in Arthritis & Rheumatology by many top lupus clinicians found that a frailty...
Reducing B Cells with Modified CAR T Cells is an Effective Treatment of Experimental Lupus: Shows Study Supported by Lupus Research Alliance
NEW YORK, NY. March 6, 2019. Depleting the number of harmful B cells with a novel immunotherapy that employs...
Lupus Therapeutics to Test Potential Treatment for Lupus in Takeda Collaboration
New York, NY– March 1. The Lupus Research Alliance and clinical affiliate, Lupus Therapeutics will partner with Takeda Pharmaceutical Company...
Lupus Research Alliance Congratulates NIH on 5-Year AMP Success
February 28, 2019
NEW YORK, NY. As a co-sponsor of the National Institutes of Health (NIH) public-private Accelerating Medicines Partnership...